CA
NZ
UK
AU
IND
US
Faeth Therapeutics (NASDAQ:FTH) shares surged to a new 52-week high as clinical-stage catalysts drew heightened investor engagement ahead of a busy September investor conference schedule. Faeth is an Austin, Texas-based clinical-stage oncology company focused on improving outcomes for cancer patients through multi-node inhibition of …
Geron (NASDAQ:GERN), a penny stock trading under $2 per share, is surging today on well-above-average volume, even as broader markets and the healthcare sector face pressure from rising bond yields and Middle East-driven oil spikes. Geron is a commercial-stage biopharmaceutical company headquartered in Foster …
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), a specialty pharmaceutical company commercializing its acid-suppression drug Voquezna, reported record revenue and rapid prescription growth in the second quarter and neared operating breakeven, though it trimmed its full-year revenue guidance.
Janux Therapeutics, Inc. (NASDAQ:JANX), a clinical-stage biotechnology company developing T-cell-engager cancer therapies, is advancing its lead prostate-cancer candidate and a broadening pipeline, backed by a very large cash position.
Alvotech (NASDAQ:ALVO), a developer and manufacturer of biosimilar medicines, reported a sharp decline in first-half revenue in 2026 as a manufacturing-improvement program temporarily disrupted output, even as it reaffirmed its full-year guidance and advanced its regulatory pipeline.
ResMed (NYSE:RMD) fell 3.64% to $231.36 at last closing. The leader in sleep-apnea and respiratory-care devices delivered strong revenue andEarningsgrowth with expanding margins in its fiscal fourth quarter, even as a safety action on its Astral ventilators created a headwind. For investors, the question …
Nutriband (NASDAQ:NTRB), trading as aPenny Stockat $4.35, fell 0.50% at last closing. The small pharmaceutical company developing an abuse-deterrent fentanyl patch called AVERSA generates minimal revenue from a contract-manufacturing operation while its lead product remains in pre-revenue development. For investors, the question is whether …
Tonix Pharmaceuticals (NASDAQ:TNXP) fell 0.85% to $13.98 at last closing. The specialty pharmaceutical company is ramping the launch of its recently approved fibromyalgia drug Tonmya, with sales and prescriptions growing rapidly, though it continues to post heavy losses and has a limited cash runway. …
Option Care Health (NASDAQ:OPCH) rose 0.81% to $23.64 at last closing. The largest U.S. provider of home and alternate-site infusion therapy beatEarningsexpectations in the second quarter with solid revenue growth, strong cash flow and share buybacks. For investors, the question is whether the company …
Kyntra Bio (NASDAQ:KYNB) rose 2.19% to $7.95 at last closing. The clinical-stage biopharmaceutical company is advancing two drug programs toward near-term clinical and regulatory catalysts, backed by a cash position extending into 2028. For investors, the question is whether it is nearing a breakout …
Please wait processing your request...